Has Lealani Acosta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,872 in general payments to Lealani Acosta, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lealani Acosta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lealani Acosta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lealani Acosta, MD

Neurology · Nashville, TNNPI 1003019902

Payments from drug & device makers

What this record shows

Sage Therapeutics, LLC accounts for 67.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,393 and has fallen 89.5% since, to $146 in 2025. That places this record below the midpoint for neurology clinicians in TN, where the typical reported total is $2,246.

$1,872in general payments, 2019–2025

Across 29 payments — averaging $64.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sage Therapeutics, LLC$1K
Neurocrine Biosciences, Inc.$176
Lilly USA, LLC$161
Teva Pharmaceuticals USA, Inc.$144
AstraZeneca$66
SK Life Science, Inc.$53
plus $18 from 1 others

$1,464,581in research payments, 2019–2025

Across 99 payments — averaging $14,794 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$1.2M
E.r. Squibb & Sons, L.L.C.$150K
Sage Therapeutics, LLC$57K
Janssen Research & Development, LLC$34K
Eli Lilly$25K

What the payments were for

Travel & lodging$89148%
Food & beverage$98152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sage Therapeutics, LLC	10	$1,255
Neurocrine Biosciences, Inc.	6	$176
Lilly USA, LLC	2	$161
Teva Pharmaceuticals USA, Inc.	8	$144
AstraZeneca	1	$66
SK Life Science, Inc.	1	$53
Acadia Pharmaceuticals Inc	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KISUNLA$121

How this compares

$1,872 in reported general payments places this provider in the 45th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$38,310

Medicare patients

211

Services billed

551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Memantine Hcl ErMemantine Hcl	123	$12,267
Rivastigmine	21	$7,030
Memantine Hcl	63	$4,344
Donepezil Hcl	270	$3,925
RivastigmineRivastigmine Tartrate	36	$3,352
Venlafaxine Hcl ErVenlafaxine Hcl	52	$1,406
Carbidopa-Levodopa ErCarbidopa/Levodopa	14	$960
Buspirone Hcl	31	$604
Mirtazapine	21	$550
Duloxetine Hcl	19	$499
Carbidopa-LevodopaCarbidopa/Levodopa	16	$393
Escitalopram Oxalate	30	$371
Clonazepam	29	$347
Paroxetine Hcl	27	$244
Levetiracetam	15	$201

Paid to pharmacies, not to this prescriber.

Other neurology in Nashville

Harold MosesNashville$438K
Daniel ClaassenNashville$285K
Francesca BagnatoNashville$167K
Philip CharlesNashville$132K
Benjamin HoffmanNashville$124K
Joy DerwenskusNashville$107K
James EatonNashville$85K
Elizabeth FerlugaNashville$77K
Britt StoneNashville$75K
Lavanya NagineniNashville$43K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →